Quality Improvement Registry

Quality Improvement Registry

Healthcare reimbursement is transitioning from pay-for-volume to a model that ties payment to quality care. The Department of Health and Human Services has set a goal to tie 90% of all Medicare payments to quality. The Centers for Medicare and Medicaid Services (CMS) seeks to reduce the overall cost of care, improve the patient experience, and improve overall population health. In addition, CMS has emphasized the need for better, coordinated care for people with cancer.

Nursing plays a critical role to identify and eliminate waste while actively improving systems and care delivery, all resulting in improved patient experiences and outcomes. ONS offers resources to inform healthcare professionals about quality reporting with an emphasis on improvement.

ONS offers 10 electronic clinical quality measures (eCQMs) to use for quality improvement and to fulfill requirements for the CMS Merit-based Incentive Payment System (MIPS).

Five ONS custom measures are approved by CMS for the Quality Payment Program (QPP).

  • Goal setting and attainment for cancer survivors
  • Exercise recommendation for adult cancer survivors.
  • Patient-reported health related quality of life during treatment for advanced cancer.
  • Assessment and intervention for immune-related adverse events during cancer treatments with checkpoint inhibitors.
  • PCR Test with MR2 or great result (BCR-ABL1 < 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia

ONS Quality Improvement Registry to Support Your Quality Improvement Activities

The ONS Quality Improvement Registry includes ONS electronic clinical quality measures (eCQMs) that have been tested for feasibility, reliability and validity. You can report on measures directly from your electronic health record and view measure performance data in dashboard format and use improvement resources to support your improvement activities.

The ONS Quality Improvement Registry is an important tool to support:

  • Practice site QI initiatives (including DNP projects)
  • ANCC Magnet requirements
  • Commission on Cancer requirements
  • Data submission to CMS for regulatory requirements

Using the ONS Quality Improvement Registry is FREE! Contact ONS staff at Research@ons.org to learn more.

Satisfy CMS Regulatory Reporting Requirements

You can take the next step in quality improvement data collection and analysis within the ONS Quality Improvement Registry and satisfy CMS regulatory reporting requirement.

The Oncology Qualified Clinical Data Registry (QCDR) is housed within the ONS Quality Improvement Registry. It is approved by CMS for Merit-Based Incentive Program (MIPS) reporting requirements and for CMS promoting interoperability reporting requirements. If you choose to submit data to CMS through the QCDR, you still have access improvement resources to support and document or attest to your improvement activities (IA). The QCDR can be used for performance improvement initiatives. NOTE: CMS offers MIPS incentives when data is reported via an approved QCDR.

If you choose to submit data to CMS, there are fees associated. Contact ONS staff at Research@ons.org to learn more.

Why Use ONS Quality Measures?
The ONS eCQMs address care priorities important to people with cancer during and after treatment. The measures address care delivered by the entire health care team, especially providing data to support the value of nursing contributions in delivering quality care.

The ONS eCQMs have been tested for feasibility, reliability and validity; you can use them with confidence and compare your performance to peers within your care setting and across the country.

Why Choose the Oncology Quality Improvement Registry?
Multi-Stakeholder Measures That Matter—Measures That Keep Quality Care as the Purpose of Measuring.

It’s free! If you choose to report data to CMS, there are associated fees, but submitting the data for QI purposes is free.

Improving your processes around these measures will achieve outcomes that matter to multiple stakeholders, most importantly the patient.

The Quality Improvement Registry offers patient-centered quality measures and tools to report your progress from baseline to continuous improvement.

Patient-Centered Care for People with Cancer
The ONS custom measures address care issues for people receiving chemotherapy and treatment-related issues for cancer survivors. These measures are appropriate for the inpatient and ambulatory setting and can be used by all care settings and specialties that provide care to cancer survivors.

Data Analysis, Benchmarking, and Dashboarding for Improvement
The Oncology QCDR differs from EHR tools and many other registries: it offers robust reporting and the ability to benchmark your data to other practices, institutions, and geographic regions. Data analyzed offer a roadmap of gaps and resources to improve the care delivered. Participation in interventions are noted on your reporting timeline and contribute to your quality improvement story and reporting. The analysis, reporting, and interventions for improvement combine to create reports that speak to your efforts in meeting value-based incentives.

Integration With Electronic Health Record Systems
You can choose to submit data using flat file formats or QCDR platform staff, Premier, Inc., will work with your informatics or IT staff or your EHR vendor to easily push data to the Oncology QCDR, minimizing staff work to collect, analyze, and report quality data. Either way, the data collection and reporting is NOT manual.

Appropriate, Useful Measures for All Oncology and Non-Oncology Care Settings

Additional cross-cutting measures, that are not specific to oncology, address care issues for inpatient and ambulatory care settings (e.g., falls prevention, medication reconciliation, pain management).

ONS Custom Quality Measures

  • Goal Setting and Attainment for Cancer Survivors
  • Fatigue Improvement
  • Exercise Recommendation to Adult Cancer Survivors
  • PCR Test with MR2 or great result (BCR-ABL1 < 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia
  • Patient Reported Health-Related Quality of Life during Treatment for Advanced Cancer
  • Assessment and Management of Immune-Related Adverse Events during Cancer Treatment with Checkpoint Inhibitors
  • Assessment and Intervention for Psychosocial Distress in Adults Receiving Cancer Treatment
  • Assessment and Intervention for Sleep-Wake Disturbance During Cancer Treatment
  • Education on Neutropenia Precautions
  • Post-Treatment Education

Quality-Related Videos

Download ONS's Qualified Clinical Data Registry Brochure Here